Introduction

!
Diabetic vascular complications are the leading cause of end-stage renal failure, acquired blindness, various neuropathies, and accelerated atherosclerosis. Chronic hyperglycemia plays a major role in the initiation of diabetic vascular complications through various hyperglycemia-induced metabolic and hemodynamic derangements, including increased AGE formation, increased polyol pathway metabolism, activation of protein kinase C isomers, and increased hexosamine biosynthesis [1] [2] [3] [4] .
Accumulation of AGE, heterogeneous molecules derived from non-enzymatic glycation between amino acid residues and oxidative derivatives of glucose or pentose, leads to the development of diabetic vascular complications, including diabetic retinopathy, neuropathy, and nephropathy [5] . Increasing evidence suggests that AGE accumulation is irreversible, causing structural and functional changes in proteins, such as collagen, elastin, and albumin. AR (aldose reductase; alditol : -NADP + 1-oxidoreductase, E. C.1.1.1.21) is the key enzyme in the polyol pathway that catalyzes NADH-dependent reduction of glucose to sorbitol. During hyperglycemic events, elevated glucose levels enhance AR activity by increasing glucose flux through the polyol pathway, inducing
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In our continuing efforts to identify effective naturally sourced agents for diabetic complications, five caffeoylated phenylpropanoid glycosides, acteoside (1), isoacteoside (2) , poliumoside (3), brandioside (4) , and pheliposide (5) were isolated from the 80 % EtOH extract of Brandisia hancei stems and leaves. These isolates (1-5) were subjected to an in vitro bioassay evaluating their inhibitory activity on advanced glycation end product formation and rat lens aldose reductase activity. All tested compounds exhibited significant inhibition of advanced glycation end product formation with IC 50 values of 4.6-25.7 µM, compared with those of aminoguanidine (IC 50 = 1056 µM) and quercetin (IC 50 = 28.4 µM) as positive controls. In the rat lens aldose reductase assay, acteoside, isoacteoside, and poliumoside exhibited greater inhibitory effects on rat lens aldose reductase with IC 50 values of 0.83, 0.83, and 0.85 µM, respectively, than those of the positive controls, 3,3-tetramethyleneglutaric acid (IC 50 = 4.03 µM) and quercetin (IC 50 = 7.2 µM). In addition, the effect of acteoside on the dilation of hyaloid-retinal vessels induced by high glucose in larval zebrafish was investigated. Acteoside reduced the diameters of high glucose-induced hyaloid-retinal vessels by 69 % at 10 µM and 81 % at 20 µM, compared to the high glucose-treated control group. These results suggest that B. hancei and its active components might be beneficial in the treatment and prevention of diabetic vascular complications. [6, 7] . Therefore, designing and developing specific pharmacological inhibitors that inhibit AGE formation or AR might provide a therapeutic approach for delaying and preventing diabetic vascular complications [8, 9] . Brandisia hancei Hook. f. (Scrophulariaceae) is a medicinal herb, primarily distributed throughout southwestern China. The whole plant is prescribed to treat chronic and acute osteomyelitis, rheumatoid arthritis, chronic hepatitis, hyperlipemia, and hypercholesterolemia, while the roots and leaves are considered useful in the treatment of hepatitis, hematuria, enterorrhagia, and metritis [10] . Previous phytochemical investigations of this plant identified numerous secondary metabolites, including a series of phenylpropanoid glycosides, phenylethanoids, flavonoids, and iridoid glycosides [10] [11] [12] [13] . In our continuing efforts to identify effective, naturally sourced therapeutic agents for diabetic complications, we found that the EtOH extract of B. hancei exhibited a considerable inhibition of AGE formation [14] . Further phytochemical study of this plant resulted in the isolation of five caffeoylated phenylpropanoid glycosides, termed 1-5. This report describes the isolation and structural elucidation of these caffeoylated phenylpropanoid glycosides, as well as the characterization of their inhibitory effects on AGE formation and RLAR. We further investigated the effect of compound 1, identified as acteoside, on the dilation of HG-induced hyaloid-retinal vessels in larval zebrafish.
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Results and Discussion
!
The 80 % EtOH extract of B. hancei stems and leaves that significantly inhibited AGE formation (IC 50 = 3.19 µg/mL) and RLAR (IC 50 = 3.27 µg/mL) was subjected to a series of chromatographic techniques. This led to the isolation of five caffeoylated phenylpropanoid glycosides (1-5) (l " Fig. 1 ). By comparing their physicochemical and spectral data with those in the literature, these isolates were identified as acteoside (1), isoacteoside (2), poliumoside (3), brandioside (4), and pheliposide (5) [11, 15, 16] . The inhibitory effects of the isolated compounds (1-5) on AGE formation and RLAR in vitro were examined as described previously [17] and results are presented in l " [19] . However, this is the first report of other caffeoylated phenylpropanoid glycosides possessing inhibitory activity on AGE formation and RLAR. The accumulation of AGE in retinal blood vessels plays an important role in the onset and development of diabetic retinopathy [20] . Experimental studies have shown that specific inhibitors of AGE formation are effective in reducing retinal microvascular lesions in diabetic animal models [21, 22] . Recently, it was reported were used as positive controls that hyperglycemia-induced adult zebrafish have an increased vessel diameter in the retina [23] . Thus, acteoside, which exhibited a potent AGE formation inhibitory activity and was isolated in a large amount, was chosen for further investigation to examine the effect on retinopathy in vivo in a diabetic zebrafish model. The change in hyaloid-retinal vessel dilation was assessed with flk:EGFP transgenic zebrafish embryos under HG (30 mM) conditions. The dilation of hyaloid-retinal vessels in larval zebrafish induced by HG was reduced by treatment with acteoside. HG-induced hyaloid-retinal vessels treated with acteoside and VEGFR inhibitor were visibly thinner than those of the HG-treated control group (l " Fig. 2 B-E), and no cytotoxicity was observed at the concentrations used. Quantitative analysis showed that acteoside reduced the diameter of HG-induced hyaloid-retinal vessels by 69 % at 10 µM and 81 % at 20 µM compared to the HG-treated control group, whereas the positive control, VEGFR inhibitor, exhibited 77% inhibition at a concentration of 1 µM (l " Fig. 2 F-G) . This suggests that acteoside inhibits the development of experimental retinopathy in the early larval stages. Development and investigation of AGE formation and AR inhibitors, particularly naturally sourced agents with few side effects, might provide a novel therapeutic approach for delaying and preventing diabetes-related complications. Of the many naturally occurring compounds previously found to inhibit AGE formation or AR, the most significant are flavonoids, such as quercetin, quercitrin, isoquercitrin, and luteolin [24, 25] . To date, more than 100 flavonoids have been reported to exhibit inhibitory activity on AGE formation or AR. The other major classes of compounds found in natural products are polyphenolics, anthraquinones, alkaloids, and monoterpene glycosides [26] [27] [28] [29] . Phenylpropanoids and their derivatives, a large conglomerate of naturally occurring phenolic compounds, are widespread throughout the plant kingdom, and various plants used in traditional medicine contain significant amounts of these compounds. They have low toxicity and a variety of pharmacological activities including antitumor, antibacterial, antiviral, analgesic, neuroprotective, hepatoprotective, anti-inflammatory, and antioxidant effects [30] [31] [32] , which makes them promising novel candidate drugs of natural origin. The current study of effective agents for diabetic complications from the stems and leaves of B. hancei resulted in the isolation of five caffeoylated phenylpropanoid glycosides (1-5): acteoside (1), isoacteoside (2), poliumoside (3), brandioside (4), and pheliposide (5).
These isolates (1-5) displayed considerable inhibition of AGE formation; acteoside and pheliposide exhibited the strongest AGE inhibition, while in the RLAR assay, acteoside, isoacteoside, and poliumoside exhibited greater inhibitory effects. Acteoside also reduced the dilation of HG-induced hyaloid-retinal vessels in a diabetic zebrafish model. These results suggest that B. hancei and its active components might be beneficial in the treatment and prevention of diabetic vascular complications and other related diseases.
Materials and Methods
!
General experimental procedures
Optical rotations were measured on a JASCO P-2000 digital polarimeter. IR spectra were recorded on a JASCO 100 IR spectrometer. 1 H (300 MHz) and 13 C NMR (75 MHz) spectra were obtained using a Bruker DRX-300 spectrometer with TMS as an internal standard. 2D-NMR experiments (COSY, HMQC, and HMBC) were run on a Bruker Avance 500 NMR spectrometer. ESI-MS were recorded on a Shimadzu LCMS-IT-TOF spectrometer. Column chromatography was performed using silica gel (70-230 mesh and 230-400 mesh; Merck), YMC-gel ODS-A (S-75 µm; YMC), and Sephadex LH-20 (Amersham Pharmacia Biotech). Thin-layer chromatography (TLC) was performed on precoated silica gel 60 F 254 (0.25 mm; Merck) and RP-18 F 254 s plates (0.25 mm; Merck). Spots were detected by UV light (254 nm) and spraying with 10 % H 2 SO 4 followed by heating. The HPLC analysis was performed on an Agilent 1200 HPLC system with a binary pump (G1312A), a vacuum degasser (G1322A), a thermostatted column compartment (G1316A), a multiple wavelength detector (G1365B; MWD), and an autosampler (G1329A), using a YMCpack Pro C 18 (S-5 µm, 150 × 4.6 mm i. d.) column.
Plant material
The stems and leaves of Brandisia hancei were collected in Songy- 
Extraction and isolation
The air-dried stems and leaves of B. hancei (3.0 kg) were extracted with 80% aqueous EtOH (each 30 L, three times) at room temperature for 7 days, filtered, and concentrated to give an 80 % EtOH extract (332 g). The extract (90 g) was subjected to silica gel column chromatography (70-230 mesh, 100 × 9.5 cm) eluted with a gradient solvent system consisting of CHCl 3 
AGE formation inhibitory assay
According to a well-established method, the reaction mixture [bovine serum albumin (10 mg/mL; Sigma; 700 µL) in 50 mM phosphate buffer (pH 7.4) with 0.02 % sodium azide] was added to 0.2 M fructose and glucose (100 µL). In screw cap tubes (1.5 mL), the reaction mixture was then mixed with 200 µL of serially diluted compounds or aminoguanidine (99 % purity; Sigma) or quercetin (99.5 % purity; Sigma). After incubating at 37°C for 7 days, the fluorescent reaction products (200 µL) were transferred to 96-well plates and assayed on a spectrofluorometric detector (Bio-Tek, Synergy HT; excitation wavelength, 350 nm; emission wavelength, 450 nm). The AGE assay was performed in triplicate. The concentration of each test sample giving 50 % inhibition of the activity (IC 50 ) was estimated from the least squares regression line of the logarithmic concentration plotted against the remaining activity.
RLAR inhibitory assay
All experimental protocols for animal care and use were approved by the Korea Institute of Oriental Medicine Institutional Animal Care and Use Committee (approval date and number; February 17, 2011 and 11-018, respectively), and animal husbandry and procedures were performed according to institutional guidelines. Rat lenses were removed from the eyes of 8-weekold Sprague-Dawley rats (Dae-Han Bio Link Co.) weighing 100-150 g and homogenized in 12 volumes of a 135 mM Na, K-phosphate buffer (pH 7.0) containing 0.5 mM phenylmethylsulfonyl fluoride and 10 mM 2-mercaptoethanol. The homogenate was centrifuged at 100 000 × g for 30 min, and the supernatant fluid was used as the crude RLAR. The incubation mixture contained 135 mM Na, K-phosphate buffer (pH 7.0), 100 mM lithium sulfate, 0.03 mM NADPH, 1 mM DL-glyceraldehyde as a substrate, and 50 µL of enzyme fraction, with or without 25 µL of sample solution, in a total volume of 1.0 mL. The reaction was initiated by the addition of NADPH at 37°C and stopped by the addition of 0.3 mL of 0.5 M HCl. Then, 1 mL of 6 M NaOH containing 10 mM imidazole was added, and the solution was heated at 60°C for 10 min to convert NADP to a fluorescent product. Fluorescence was measured using a spectrofluorometric detector (Shimadzu RF-5301PC, Ex: 360, Em: 460 nm). The concentration of each test sample giving 50 % inhibition of the activities (IC 50 ) was estimated from the least squares regression line of the logarithmic concentration plotted against the remaining activity. 3,3-Tetramethyleneglutaric acid (99% purity; Aldrich) and quercetin (99.5 % purity; Sigma) were used as positive controls.
Measurement of vessel dilation in larval zebrafish
All experimental protocols for animal care and use were approved by the Korea Institute of Oriental Medicine Institutional Animal Care and Use Committee (approval date and number; March 19, 2012 and 12-020, respectively), and animal husbandry and procedures were performed according to institutional guidelines. Adult zebrafish were maintained under standard conditions at 28.5°C with a 14-h light/10-h dark cycle. Embryos were obtained from crosses between flk:EGFP Tg (transgenic) fish and raised in egg water (sea salt, 0.06 g/L). On day 1 flk:EGFP Tg embryos were placed into a 24-well plate (five embryos per well) and maintained in 2 mL of egg water containing 30 mM glucose. HG-induced embryos were treated with compound 1 (10 µM or 20 µM) days 1-6 post-fertilization (dpf). At 6 dpf, HG-induced embryos were fixed with 4 % paraformaldehyde, and the lenses containing hyaloid-retinal vessels were isolated. Fluorescence was visualized using an Olympus SZX16 stereomicroscope, and diameters were analyzed using ImageJ software. Experiments were performed in triplicate. Vascular endothelial growth factor receptor inhibitor (99.4 % purity; Calbiochem) was used as a positive control.
Statistical analysis
Hyaloid vessel diameter was used to calculate the percentage inhibition of compound 1 in HG-treated embryos according to the formula:
Percentage inhibition (%) = 100 -[(T-C)/(HG-C)] × 100, where C = hyaloid-vessel diameter (AU) of the control embryos; HG = hyaloid-vessel diameter (AU) of the HG-treated embryos; T = hyaloid-vessel diameter (AU) of the HG-treated embryos treated with compound 1. The results are expressed as means ± SEM from multiple experiments. Statistical significance was assessed using ANOVA and Dunnettʼs multiple comparison tests with the GraphPad 5.0 Prism software (GraphPad).
